- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-524/23: Action brought on 24 August 2023 — Boehringer Ingelheim Pharma v EUIPO — Glenmark Pharmaceuticals Europe (Shape of inhaler)
ECLI:EU:UNKNOWN:62023TN0524
62023TN0524
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
Series C
C/2023/72
9.10.2023
(Case T-524/23)
(C/2023/72)
Language in which the application was lodged: English
Parties
Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG (Ingelheim, Germany) (represented by: I. Fowler and C. Stöber, lawyers)
Defendant: European Union Intellectual Property Office
Other party to the proceedings before the Board of Appeal: Glenmark Pharmaceuticals Europe Ltd (Watford, United Kingdom)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Applicant before the General Court
Trade mark at issue: European Union tridimensional mark (Shape of inhaler) –European Union trade mark No 1 243 484
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the Forth Board of Appeal of EUIPO of 13 June 2023 in Case R 1558/2021-4
Form of order sought
The applicant claims that the Court should:
—annul the contested decision;
—order that the costs of the proceedings be borne by the defendant, and in the event that the other party before the Board of Appeal joins the proceedings, by the intervener.
Plea(s) in law
—Infringement of Article 59(1)(a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in conjunction with Article 7(1)(e)(ii) of Council Regulation (EC) No 40/94;
—Infringement of Article 94 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.